RecruitingNot Applicable

Comparative Effects of Aerobic Exercises and Jacobson's Progressive Relaxation Technique in Primary Dysmenorrhea

Pakistan58 participantsStarted 2025-10-01

Plain-language summary

The study will focus on the comparative effects of aerobic exercises and Jacobson's progressive relaxation technique on pain, fatigue and quality of life in primary dysmenorrhea. This study will be a randomized clinical trial and will be conducted in, Superior college depalpur and Army public schools and college Lahore (APSACS). Non probability convenience sampling will be used to collect the data.64 participants will be selected on the basis of inclusion and exclusion criteria and will be equally divided into two groups by sealed opaque enveloped .Participants having age group between 17-24 years and diagnosed with WaLiDD score are included.

Who can participate

Age range

17 Years – 24 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Pain on numeric rating pain scale, * Menarche range 12-16, * BMI less than 30, * Having a regular menstrual cycle (28-32) days, * Normal bleeding days (3 to 1) and diagnosed with mild PD according to WaLiDD score Exclusion Criteria: * Athletes, * married women with gynaecological abnormalities were excluded, * Medical treatment during the study (e.g., oral contraceptives, antidepressants) * Recent musculoskeletal trauma or surgery, or chronic musculoskeletal disorders * affecting pain perception (e.g., fibromyalgia, pelvic floor dysfunction) * secondary dysmenorrhea-related conditions (e.g., endometriosis, fibroids, ovarian cysts), * consumption of painkillers * No mental or physical diseases, which reduce the abilities to exercise

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

WaLlDD relaxation technique on pain, fatigue and quality of life in primary dysmenorrhea.

Timeframe: 2 months

Fatigue Assessment Scale

Timeframe: 2 months

EQ-5D-5-L-Questionnaire

Timeframe: 2 months

Trial details

NCT IDNCT07628452

SponsorRiphah International University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-07-01

Contact for this trial

Imran Amjad, PhD

03324390125 imran.amjad@riphah.edu.pk

View on ClinicalTrials.gov More Dysmenorrhea trials

Plain-language summary

Who can participate

Age range

17 Years – 24 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.